KLENZAIDS CONTAMINATION CONTROLS PRIVATE LIMITED Revenue and Competitors
Estimated Revenue & Valuation
- KLENZAIDS CONTAMINATION CONTROLS PRIVATE LIMITED's estimated annual revenue is currently $6.9M per year.
- KLENZAIDS CONTAMINATION CONTROLS PRIVATE LIMITED's estimated revenue per employee is $110,250
Employee Data
- KLENZAIDS CONTAMINATION CONTROLS PRIVATE LIMITED has 63 Employees.
- KLENZAIDS CONTAMINATION CONTROLS PRIVATE LIMITED grew their employee count by 24% last year.
KLENZAIDS CONTAMINATION CONTROLS PRIVATE LIMITED's People
Name | Title | Email/Phone |
---|
KLENZAIDS CONTAMINATION CONTROLS PRIVATE LIMITED Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $9.8M | 80 | 1% | $10M | N/A |
#2 | $11.6M | 95 | 2% | N/A | N/A |
#3 | $85.4M | 549 | -3% | $49.4M | N/A |
#4 | $147.1M | 858 | 8% | N/A | N/A |
#5 | $3.9M | 40 | -13% | N/A | N/A |
#6 | $4.5M | 46 | 5% | N/A | N/A |
#7 | $3.4M | 35 | -3% | $3M | N/A |
#8 | $24.8M | 184 | -1% | N/A | N/A |
#9 | $56.5M | 369 | 13% | N/A | N/A |
#10 | $169.8M | 990 | 9% | N/A | N/A |
What Is KLENZAIDS CONTAMINATION CONTROLS PRIVATE LIMITED?
Klenzaids delivers Regulatory Compliant Turnkey "Design-Buildâ??Projects within:\n\nA | Aseptic\nB | BioClean\nC | Containment\n\nThese include Cleanrooms; Biological-Chemical Containment Facilities and Laboratories; Microenvirons and Laboratories for Active Ingredients and Formulations in the Pharmaceutical, Life-Science, BioTechnology, Electronics, Aerospace, Food, Healthcare and Cosmetic sectors. \n\nKlenzaids known for its strong IPR and patents, manufactured specialized benchmark equipments and devices, for clients across the globe.
keywords:N/AN/A
Total Funding
63
Number of Employees
$6.9M
Revenue (est)
24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.1M | 63 | 3% | N/A |
#2 | $8.2M | 63 | N/A | N/A |
#3 | $4M | 63 | 24% | N/A |
#4 | $6.4M | 63 | 40% | N/A |
#5 | N/A | 63 | 7% | N/A |